Christian S. Schade
2020
In 2020, Christian S. Schade earned a total compensation of $3.9M as President and Chief Executive Officer at Aprea Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $283,250 |
|---|---|
| Option Awards | $3,107,690 |
| Salary | $515,000 |
| Total | $3,905,940 |
Schade received $3.1M in option awards, accounting for 80% of the total pay in 2020.
Schade also received $283.3K in non-equity incentive plan and $515K in salary.
Rankings
In 2020, Christian S. Schade's compensation ranked 2,927th out of 13,090 executives tracked by ExecPay. In other words, Schade earned more than 77.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,927 out of 13,090 | 78th |
Division Manufacturing | 1,130 out of 5,621 | 80th |
Major group Chemicals And Allied Products | 420 out of 2,254 | 81st |
Industry group Drugs | 363 out of 1,954 | 81st |
Industry Pharmaceutical Preparations | 267 out of 1,459 | 82nd |
Source: SEC filing on April 28, 2021.
Schade's colleagues
We found two more compensation records of executives who worked with Christian S. Schade at Aprea Therapeutics in 2020.
News
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020